Global Transcriptomics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Transcriptomics market size will reach 5,375.72 Million USD in 2025 and is projected to reach 10,244.65 Million USD by 2032, with a CAGR of 9.65% (2025-2032). Notably, the China Transcriptomics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Transcriptomics is a field of molecular biology that focuses on the study of the complete set of RNA transcripts present in a cell, tissue, or organism, collectively known as the transcriptome. The transcriptome represents the active genes and their expression levels at a specific point in time. Transcriptomics involves techniques such as RNA sequencing (RNA-Seq) to analyze and quantify the entire transcriptome, providing valuable insights into gene expression patterns, alternative splicing, and post-transcriptional modifications. Researchers use transcriptomics to understand the molecular mechanisms underlying various biological processes, including development, disease, and response to external stimuli. The data generated from transcriptomic studies contribute to a more comprehensive understanding of cellular functions, identification of biomarkers, and the discovery of potential therapeutic targets in fields ranging from basic research to clinical applications.
The major global suppliers of Transcriptomics include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Transcriptomics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Transcriptomics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Transcriptomics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Transcriptomics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Transcriptomics Include:
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Transcriptomics Product Segment Include:
PCR
Microarray
Sequencing
Transcriptomics Product Application Include:
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Transcriptomics Industry PESTEL Analysis
Chapter 3: Global Transcriptomics Industry Porter's Five Forces Analysis
Chapter 4: Global Transcriptomics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Transcriptomics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Transcriptomics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Transcriptomics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Transcriptomics market size will reach 5,375.72 Million USD in 2025 and is projected to reach 10,244.65 Million USD by 2032, with a CAGR of 9.65% (2025-2032). Notably, the China Transcriptomics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Transcriptomics is a field of molecular biology that focuses on the study of the complete set of RNA transcripts present in a cell, tissue, or organism, collectively known as the transcriptome. The transcriptome represents the active genes and their expression levels at a specific point in time. Transcriptomics involves techniques such as RNA sequencing (RNA-Seq) to analyze and quantify the entire transcriptome, providing valuable insights into gene expression patterns, alternative splicing, and post-transcriptional modifications. Researchers use transcriptomics to understand the molecular mechanisms underlying various biological processes, including development, disease, and response to external stimuli. The data generated from transcriptomic studies contribute to a more comprehensive understanding of cellular functions, identification of biomarkers, and the discovery of potential therapeutic targets in fields ranging from basic research to clinical applications.
The major global suppliers of Transcriptomics include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Transcriptomics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Transcriptomics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Transcriptomics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Transcriptomics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Transcriptomics Include:
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Transcriptomics Product Segment Include:
PCR
Microarray
Sequencing
Transcriptomics Product Application Include:
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Transcriptomics Industry PESTEL Analysis
Chapter 3: Global Transcriptomics Industry Porter's Five Forces Analysis
Chapter 4: Global Transcriptomics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Transcriptomics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Transcriptomics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Transcriptomics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Transcriptomics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Transcriptomics Product by Type
- 1.2.1 PCR
- 1.2.2 Microarray
- 1.2.3 Sequencing
- 1.3 Transcriptomics Product by Application
- 1.3.1 Pharmaceutical and Biotechnology
- 1.3.2 Academic Research and Government Institutes
- 1.3.3 Hospitals and Diagnostic Centers
- 1.4 Global Transcriptomics Market Size Analysis (2020-2032)
- 1.5 Transcriptomics Market Development Status and Trends
- 1.5.1 Transcriptomics Industry Development Status Analysis
- 1.5.2 Transcriptomics Industry Development Trends Analysis
- 2 Transcriptomics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Transcriptomics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Transcriptomics Market Analysis by Country
- 4.1 Global Transcriptomics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Transcriptomics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Transcriptomics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.5 China Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.6 France Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.14 India Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Transcriptomics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Transcriptomics Market Revenue by Key Suppliers (2021-2025)
- 5.2 Transcriptomics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Transcriptomics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Transcriptomics Market Analysis by Type
- 6.1 Global Transcriptomics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Transcriptomics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Thermo Fisher Scientific
- 7.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Thermo Fisher Scientific Transcriptomics Product Portfolio
- 7.1.3 Thermo Fisher Scientific Transcriptomics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Illumina
- 7.2.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Illumina Transcriptomics Product Portfolio
- 7.2.3 Illumina Transcriptomics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 QIAGEN (Exiqon)
- 7.3.1 QIAGEN (Exiqon) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 QIAGEN (Exiqon) Transcriptomics Product Portfolio
- 7.3.3 QIAGEN (Exiqon) Transcriptomics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Agilent Technologies
- 7.4.1 Agilent Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Agilent Technologies Transcriptomics Product Portfolio
- 7.4.3 Agilent Technologies Transcriptomics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Roche
- 7.5.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Roche Transcriptomics Product Portfolio
- 7.5.3 Roche Transcriptomics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 GE Healthcare
- 7.6.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 GE Healthcare Transcriptomics Product Portfolio
- 7.6.3 GE Healthcare Transcriptomics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Bio-Rad Laboratories
- 7.7.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Bio-Rad Laboratories Transcriptomics Product Portfolio
- 7.7.3 Bio-Rad Laboratories Transcriptomics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Fluidigm
- 7.8.1 Fluidigm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Fluidigm Transcriptomics Product Portfolio
- 7.8.3 Fluidigm Transcriptomics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Transcriptomics Industry Chain Analysis
- 8.2 Transcriptomics Product Downstream Application Analysis
- 8.2.1 Global Transcriptomics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Transcriptomics Revenue and Forecast by Application (2020-2032)
- 8.3 Transcriptomics Typical Downstream Customers
- 8.4 Transcriptomics Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
